Destiny-Pharma
2 known investors
Find your way into Destiny-Pharma
AMR Bio is a clinical-phase biotechnology company developing novel anti-infective drugs focused on infection prevention and combating antibiotic resistance.
Investors · 2
Frequently asked questions
- What does Destiny-Pharma do?
- AMR Bio is a clinical-phase biotechnology company developing novel anti-infective drugs focused on infection prevention and combating antibiotic resistance.
- Who are Destiny-Pharma's investors?
- Destiny-Pharma's investors include Juno Capital Partners, Seneca Partners.